- Issuer ticker
-
ARMP
- Reported as of
-
09 Mar 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
11 Mar 2026, 21:18:25 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Robin Kramer
Key filing fact
Robin Kramer filed Form 4 for Armata Pharmaceuticals, Inc. (ARMP) on 11 Mar 2026.
Key facts
- This page summarizes Robin Kramer's Form 4 filing for Armata Pharmaceuticals, Inc. (ARMP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 11 Mar 2026, 21:18.
Change
- Previous filing in this sequence was filed on 17 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001609222
Primary reporting owner
Kramer Robin
- Relationship
-
Director
- Address
- 5005 MCCONNELL AVENUE, LOS ANGELES
- Signature
- /s/ Robin Kramer
- Signature date
- 11 Mar 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARMP
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- Shares
- +25,640
- Change %
- Price
-
$0.000000*
- Shares after
- 25,640
- Date
- 09 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,640
- Exercise price
- $11.61
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote